26.05.2023 - NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) - Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported operational highlights and financial results for the period ended March .
Mesoblast Limited (OTCMKTS:MEOBF – Get Rating) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 117,700 shares, a decrease of 89.4% from the April 30th total of 1,110,200 shares. Based on an average daily volume of 0 shares, the days-to-cover […]
Mesoblast Reports Operational and Financial Highlights for Quarter Ended March 31, 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Shares of Mesoblast Limited (OTCMKTS:MEOBF – Get Rating) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.62 and traded as high as $0.78. Mesoblast shares last traded at $0.78, with a volume of 100 shares trading hands. Mesoblast Price Performance The firm has a […]
Mesoblast Limited (NASDAQ:MESO – Get Rating)’s share price shot up 3.2% during trading on Tuesday . The company traded as high as $3.85 and last traded at $3.82. 54,816 shares traded hands during trading, a decline of 61% from the average session volume of 139,828 shares. The stock had previously closed at $3.70. Wall Street […]